Marilyn De La Cruz

Title: Innovations by Marilyn De La Cruz

Introduction

Marilyn De La Cruz is a prominent inventor based in Matawan, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of new manufacturing processes and compounds. With a total of 4 patents to her name, her work has had a substantial impact on medical treatments.

Latest Patents

One of her latest patents focuses on a manufacturing process for pyrimidine derivatives. This invention relates to new crystalline forms and processes for manufacturing a compound of formula 5, or its stereoisomers, tautomers, or salts. The invention also encompasses new manufacturing processes for specific solid forms of Compound A and its salts, which are intended for therapeutic treatment of warm-blooded animals. Another notable patent involves the development of hydrochloride, malate, oxalate, and tartrate salt forms of a specific compound, which includes pharmaceutical compositions and processes for forming these salts. Additionally, this patent addresses new polymorphic forms of these salts and their medical applications.

Career Highlights

Marilyn De La Cruz is currently associated with Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to focus on innovative solutions in the pharmaceutical industry. Her contributions have been instrumental in advancing the field and improving patient outcomes.

Collaborations

Throughout her career, Marilyn has collaborated with notable colleagues such as Piotr Henryk Karpinski and Yugang Liu. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Marilyn De La Cruz is a trailblazer in the pharmaceutical industry, with a strong portfolio of patents that reflect her dedication to innovation. Her work continues to influence medical treatments and improve the quality of healthcare.